Rob Dillard

DocwireNews

According to the findings of a study published in the Journal of the National Comprehensive Cancer Network enrollment in life-extending clinical trials <a href="https://www.docwirenews.com/docwire-pick/understanding-the-phases-of-clinical-trials/">for</a> cancer treatment is low, except among white males with private insurance.In this study, a team of Penn State Cancer Institute researchers assessed data from more than 12 million patients with 46 different types of cancer between 2004 and 2015 in the National Cancer Database. Subsequently, they performed a stratified analysis in which they matched each patient who participated in any clinical trials with another patient who was not enrolled in a trial that had ten similar characteristics &mdash; including cancer type, age, race, insurance type, disease stage, and whether or not surgery or chemotherapy were part of the treatment plan.The researchers observed that only 11,576 (0.1%) of those patients enrolled in clinical trials as their first course of therapy following diagnosis. &ldquo;Major advances in cancer treatment have been supported by clinical trials,&rdquo; said Dr. Niraj J. Gusani, professor of surgery, Penn State College of Medicine, and senior author of the study in a <a href="https://www.eurekalert.org/pub_releases/2020-01/ps-sfc012020.php">press release</a>. &ldquo;By volunteering to participate in a trial, patients may help further the field of research and gain access to new treatments.&rdquo;According to Dr. Nicholas G. Zaorsky, previous evaluations of whether clinical trials improved survival compared patients who were enrolled in trials against those not enrolled in trials &mdash; but didn&rsquo;t account for factors like age, race, gender and cancer type.&ldquo;If you&rsquo;re going to evaluate whether clinical trial enrollment is beneficial for patients, you have to try and match each patient to someone who has a similar cancer and sociodemographic profile,&rdquo; Zaorsky said. &ldquo;Otherwise, it is like comparing apples to oranges.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
this is a good article from Penn State <a href="https://t.co/1sOILdF3Bn">https://t.co/1sOILdF3Bn</a> @PennStatePatient <a href="https://twitter.com/PennState?ref_src=twsrc%5Etfw">@PennState</a> <a href="https://twitter.com/hashtag/medical?src=hash&amp;ref_src=twsrc%5Etfw">#medical</a> <a href="https://twitter.com/Ama?ref_src=twsrc%5Etfw">@AMA</a> <a href="https://twitter.com/hashtag/Medical?src=hash&amp;ref_src=twsrc%5Etfw">#Medical</a> <a href="https://twitter.com/hashtag/Cancer?src=hash&amp;ref_src=twsrc%5Etfw">#Cancer</a> <a href="https://twitter.com/hashtag/DYK?src=hash&amp;ref_src=twsrc%5Etfw">#DYK</a> <a href="https://twitter.com/hashtag/EndCancer?src=hash&amp;ref_src=twsrc%5Etfw">#EndCancer</a> <a href="https://twitter.com/hashtag/tumor?src=hash&amp;ref_src=twsrc%5Etfw">#tumor</a> Select few cancer patients enroll in potentially life-extending clinical trials.
&mdash; unsocial truth (@knitz22) <a href="https://twitter.com/knitz22/status/1219681042660913153?ref_src=twsrc%5Etfw">January 21, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Dr. Gusani added that: &ldquo;If clinical trials are going to be used to determine standards of care for the general population, then the study participants need to be representative of the general population &mdash; and this study shows that often this isn&rsquo;t the case.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Patient enrollment in clinical trials as the first course of treatment after cancer diagnosis is low, despite the fact that enrollment may increase life expectancy, according to researchers at <a href="https://twitter.com/penn_state?ref_src=twsrc%5Etfw">@Penn_State</a>. <a href="https://t.co/ejPbNa33F6">https://t.co/ejPbNa33F6</a>
&mdash; Art Fridrich (@Ahighervision) <a href="https://twitter.com/Ahighervision/status/1219683085131964417?ref_src=twsrc%5Etfw">January 21, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Not Enough Cancer Patients Enroll in Potentially Life-Extending Clinical Trials

Oncology

According to the findings of a study published in the Journal of the National Comprehensive Cancer Network enrollment in life-extending clinical trials for cancer treatment is ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe